A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 22, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Oct 24, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PRRUF SEC filings page.
IMMUTEP LTD (PRRUF) reported $6.8M in revenue for fiscal year 2025, up 29.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
IMMUTEP LTD does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
IMMUTEP LTD passes 1 of 7 computable financial strength tests (2 of the nine could not be computed from available data). No profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) passes.
IMMUTEP LTD reported a net loss of $40.4M while operations used $40.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
IMMUTEP LTD generated $6.8M in revenue in fiscal year 2025. This represents an increase of 29.7% from the prior year.
IMMUTEP LTD reported a net loss of $40.4M in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.
IMMUTEP LTD earned -$0.03 per diluted share (EPS) in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.
Not reported for fiscal year 2025.
Cash & Balance Sheet
IMMUTEP LTD recorded an outflow of $40.8M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. The change from the prior year is not meaningful, because that figure was zero or negative.
IMMUTEP LTD held $44.3M in cash as of fiscal year 2025; no long-term debt figure is on record for that period.
Not reported for fiscal year 2025.
Margins & Returns
IMMUTEP LTD's ROE was -42.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 20.2 percentage points from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
IMMUTEP LTD invested $32.7M in research and development in fiscal year 2025. This represents an increase of 55.7% from the prior year.
IMMUTEP LTD invested $30K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 54.2% from the prior year.
Not reported for fiscal year 2025.
PRRUF Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.8M+29.7% | $5.2M+51.1% | $3.5M-25.7% | $4.7M+56.9% | $3.0M-73.8% | $11.4M+116.7% | $5.2M-3.5% | $5.4M+67.9% | $3.2M+114.9% | $1.5M |
| R&D Expenses | $32.7M+55.7% | $21.0M+9.5% | $19.2M+9.7% | $17.5M+94.2% | $9.0M-16.1% | $10.7M+11.2% | $9.7M+30.6% | $7.4M+28.0% | $5.8M+10.1% | $5.2M |
| Interest Expense | $24K+19.3% | $20K+50.3% | $14K-78.7% | $64K+766.6% | $7K+2.2% | $7Kn/m | $0 | N/A | N/A | $6K |
| Income Tax | $0n/m | $0n/m | $0-100.0% | $23-5.1% | $25-3.0% | $26n/m | $0-100.0% | $1Kn/m | -$566Kn/m | -$878K |
| Net Income | -$40.4Mn/m | -$28.5Mn/m | -$26.6Mn/m | -$22.2Mn/m | -$22.4Mn/m | -$9.3Mn/m | -$12.9Mn/m | -$9.4Mn/m | -$7.2Mn/m | -$46.1M |
| EPS (Basic) | -$0.03n/m | -$0.02n/m | -$0.03n/m | -$0.03n/m | -$0.04n/m | -$0.02 | -$3.71n/m | -$3.43 | -$0.31n/m | -$2.07 |
| EPS (Diluted) | -$0.03n/m | -$0.02n/m | -$0.03n/m | -$0.03n/m | -$0.04n/m | -$0.02 | -$3.71n/m | -$3.43 | -$0.31n/m | -$2.07 |
| Diluted Shares (Avg) | 1.46B+21.2% | 1.20B+34.6% | 892M+5.1% | 849M+42.7% | 595M+44.1% | 413M | 347M+26.1% | 275M | 2.37B+6.4% | 2.23B |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, SG&A Expenses, Operating Income, EBITDA.
PRRUF Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $103.2M-23.3% | $134.6M+37.0% | $98.2M+39.3% | $70.5M+14.7% | $61.5M+91.4% | $32.1M+13.0% | $28.4M-18.3% | $34.8M+29.6% | $26.8M-15.1% | $31.6M |
| Current Assets | $98.0M-23.3% | $127.8M+42.1% | $89.9M+43.4% | $62.7M+22.3% | $51.3M+138.8% | $21.5M+30.1% | $16.5M-22.1% | $21.2M+73.4% | $12.2M | N/A |
| Cash & Equivalents | $44.3M-59.0% | $108.0M+31.4% | $82.2M+48.9% | $55.2M+21.6% | $45.4M+150.3% | $18.1M+56.2% | $11.6M-33.1% | $17.4M+84.9% | $9.4M-39.5% | $15.5M |
| Accounts Receivable | $6.5M+32.2% | $4.9M-7.4% | $5.3M-8.4% | $5.8M+25.9% | $4.6M+102.2% | $2.3M-37.6% | $3.6M+43.4% | $2.5M+50.8% | $1.7M | N/A |
| Goodwill | $4.7M-14.0% | $5.5M-13.0% | $6.3M-13.2% | $7.3M-24.3% | $9.6M-8.1% | $10.5M-11.8% | $11.9M-12.4% | $13.6M-7.1% | $14.6M-5.8% | $15.5M |
| Total Liabilities | $8.8M+9.0% | $8.1M+10.0% | $7.3M+30.9% | $5.6M-14.9% | $6.6M-28.4% | $9.2M-19.0% | $11.3M+13.5% | $10.0M+54.1% | $6.5M+20.3% | $5.4M |
| Current Liabilities | $8.4M+19.8% | $7.0M+7.5% | $6.5M+47.0% | $4.4M+10.6% | $4.0M+72.6% | $2.3M-37.6% | $3.7M+30.3% | $2.9M+41.1% | $2.0M | N/A |
| Non-Current Liabilities | $387K-63.1% | $1.0M+30.4% | $805K-30.5% | $1.2M-54.8% | $2.6M-62.6% | $6.8M-10.0% | $7.6M+6.8% | $7.1M+59.9% | $4.5M | N/A |
| Total Equity | $94.4M-25.4% | $126.5M+39.2% | $90.9M+40.0% | $65.0M+18.3% | $54.9M+139.3% | $23.0M+34.3% | $17.1M-31.1% | $24.8M+21.8% | $20.4M-22.4% | $26.2M |
| Retained Earnings | -$291.9Mn/m | -$255.5Mn/m | -$226.5Mn/m | -$208.8Mn/m | -$205.9Mn/m | -$190.0Mn/m | -$183.8Mn/m | -$181.0Mn/m | -$178.0M | N/A |
Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments, Long-Term Debt.
PRRUF Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$40.8Mn/m | -$23.3Mn/m | -$23.6Mn/m | -$20.9Mn/m | -$13.2Mn/m | -$7.5Mn/m | -$10.7Mn/m | -$5.8Mn/m | -$6.5Mn/m | -$8.4M |
| Capital Expenditures | $30K+54.2% | $20K-64.6% | $55K+248.4% | $16K+35.3% | $12K-12.3% | $13K-54.1% | $29K+230.0% | $9K+72.5% | $5K-74.7% | $20K |
| Free Cash Flow | -$40.8Mn/m | -$23.3Mn/m | -$23.6Mn/m | -$20.9Mn/m | -$13.2Mn/m | -$7.5Mn/m | -$10.7Mn/m | -$5.8Mn/m | -$6.5Mn/m | -$8.4M |
| Investing Cash Flow | -$25.3Mn/m | -$14.0Mn/m | -$55Kn/m | -$16Kn/m | -$12Kn/m | -$13Kn/m | -$29Kn/m | -$9Kn/m | -$5K-106.7% | $76K |
| Financing Cash Flow | -$345K-100.5% | $63.6M+25.5% | $50.7M+45.8% | $34.7M-12.0% | $39.5M+179.8% | $14.1M+151.3% | $5.6M-58.8% | $13.6Mn/m | -$7K-100.0% | $19.1M |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Dividends Paid, Share Buybacks.
PRRUF Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | -594.6% | -545.0% | -767.2% | -476.6% | -753.6% | -81.6% | -244.9% | -173.3% | -221.9% | -3056.6% |
| Return on Equity | -42.8%-20.2pp | -22.5%+6.7pp | -29.2%+5.0pp | -34.2%+6.6pp | -40.8%-0.4pp | -40.5%+34.8pp | -75.2%-37.2pp | -38.0%-2.7pp | -35.3%+140.3pp | -175.6% |
| Return on Assets | -39.1%-17.9pp | -21.2%+5.9pp | -27.1%+4.5pp | -31.5%+4.9pp | -36.4%-7.6pp | -28.9%+16.4pp | -45.3%-18.1pp | -27.1%-0.3pp | -26.8%+118.9pp | -145.7% |
| Current Ratio | 11.69-6.6x | 18.25+4.4x | 13.81-0.3x | 14.16+1.3x | 12.81+3.6x | 9.26+4.8x | 4.44-3.0x | 7.43+1.4x | 6.05 | N/A |
| Liabilities-to-Equity | 0.090.0x | 0.060.0x | 0.080.0x | 0.090.0x | 0.12-0.3x | 0.40-0.3x | 0.66+0.3x | 0.40+0.1x | 0.32+0.1x | 0.20 |
| Asset Turnover | 0.070.0x | 0.040.0x | 0.040.0x | 0.070.0x | 0.05-0.3x | 0.35+0.2x | 0.180.0x | 0.160.0x | 0.12+0.1x | 0.05 |
| FCF Margin | -601.0% | -444.6% | -681.5% | -447.7% | -444.9% | -65.8% | -204.7% | -105.9% | -201.7% | -558.8% |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Debt-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin, FCF Margin.
Where IMMUTEP LTD Ranks
Frequently Asked Questions
What is IMMUTEP LTD's annual revenue?
IMMUTEP LTD (PRRUF) reported $6.8M in total revenue for fiscal year 2025. This represents a 29.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is IMMUTEP LTD's revenue growing?
IMMUTEP LTD (PRRUF) revenue grew by 29.7% year-over-year, from $5.2M to $6.8M in fiscal year 2025.
Is IMMUTEP LTD profitable?
No, IMMUTEP LTD (PRRUF) reported a net loss of $40.4M in fiscal year 2025.
What is IMMUTEP LTD's return on equity (ROE)?
IMMUTEP LTD (PRRUF) has a return on equity of -42.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is IMMUTEP LTD's free cash flow?
IMMUTEP LTD (PRRUF) recorded an outflow of $40.8M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is IMMUTEP LTD's operating cash flow?
IMMUTEP LTD (PRRUF) recorded an outflow of $40.8M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are IMMUTEP LTD's total assets?
IMMUTEP LTD (PRRUF) had $103.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are IMMUTEP LTD's capital expenditures?
IMMUTEP LTD (PRRUF) invested $30K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does IMMUTEP LTD spend on research and development?
IMMUTEP LTD (PRRUF) invested $32.7M in research and development during fiscal year 2025.
What is IMMUTEP LTD's current ratio?
IMMUTEP LTD (PRRUF) had a current ratio of 11.69 as of fiscal year 2025, which is generally considered healthy.
What is IMMUTEP LTD's liabilities-to-equity ratio?
IMMUTEP LTD (PRRUF) had a liabilities-to-equity ratio of 0.09 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
What is IMMUTEP LTD's return on assets (ROA)?
IMMUTEP LTD (PRRUF) had a return on assets of -39.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is IMMUTEP LTD's P/E ratio?
IMMUTEP LTD (PRRUF) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $24.8M as of Oct 22, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is IMMUTEP LTD's price-to-sales ratio?
IMMUTEP LTD (PRRUF) trades at 3.6x sales, its market capitalization divided by $6.8M revenue, FY2025. The market capitalization is $24.8M as of Oct 22, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is IMMUTEP LTD's Piotroski F-Score?
IMMUTEP LTD (PRRUF) has a Piotroski F-Score of 1 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are IMMUTEP LTD's earnings high quality?
IMMUTEP LTD (PRRUF) reported a net loss of $40.4M while operations used $40.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.